Personalized ADHD Medication Experiments to Inform Decisions About Continued Medication Use: An Open-Label Trial

Key Points

• Treatment decisions regarding ADHD medication are informed by personalized medication experiments, highlighting the importance of individualized care.
• The trial assesses the effects of medication on ADHD symptoms and the implications for ongoing treatment.
• Participants in the open-label trial received tailored ADHD medications to inform future treatment paths, enhancing treatment relevance.
• Findings suggest improved decision-making for ADHD treatment, indicating the potential for personalized medicine in this context.